Loading…
← CockpitCompetitor Analysis › 4919.T Milbon Co., Ltd.Open in the cockpit ↗

Milbon Co., Ltd.4919.TCompetitor analysis, valuation and peers

Japan · JPY·Consumer Staples›Household/Personal Care
Momentum leader 96
Mkt cap
$743M
US dollars, full cap
Free float
76%
of shares outstanding
$/day
$4.16M
20-day average traded
Fwd P/E
25.7×
forward earnings
ROIC−WACC
+9.2 pp
WACC 5.0%
Hurdle
-11 pp
Req g minus delivered
Next earnings
86 days
12 Feb 2027
Close · JPY¥3,755
1D-1.1%
1W+11.9%
1M+10.0%
3M+15.5%
6M+47.8%
YTD+54.2%
1Y+58.8%
ATR %2.6%
52w lowhigh2.5% off high

What Milbon does

Employees: 1,237

Milbon at a glance

Size Milbon (4919.T) is a Japan Consumer Staples company (Household/Personal Care) with a market value of $743M, the 874th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥3,755 on 18 Nov 2026.

Performance Over six months the shares gained 47.8%, against -12.0% for the median peer and -1.4% for the Japan market (cap-weighted) — 3rd highest of 21 in its peer set.

Growth Revenue grew 7.7% over the last twelve months (peer median +11.5%); the operating margin is 14.1% (peer median 8.8%).

Valuation It trades at 25.7× forward earnings against a peer median of 18.5× (7th most expensive of 20).

Price implies For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -11 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 9.2 points above its cost of capital (5.0% WACC).

Next results Next results expected around 12 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 20264919.T 137Peer median 90
Six months, rebased to 100: Milbon against the median of its 20 peers (local-currency closes).

Milbon financials

Reported figures in JPY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥56.2B¥52.9B¥51.3B¥47.8B¥45.2B
Revenue growth—+3%+7%+6%—
Gross profit¥35.8B¥33.2B¥32.6B¥29.5B¥29.5B
EBITDA¥10.3B¥7.75B¥9.11B¥7.80B¥9.63B
Net income¥5.89B¥3.44B¥5.02B¥4.00B¥5.58B
Free cash flown/a¥2.44B¥5.43B¥2.17B¥1.95B
Capital expendituren/a¥3.33B¥2.54B¥3.21B¥3.82B
Total debt¥0¥0¥0¥0¥0

Quarterly statements and history in the cockpit →

Milbon competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%0%605009JYOTHYLAB300740GALAXYSURF2417100013286031933011084928BAJAJCON2657PZC4836502145001206EPC6036300030060012304919.T6-month return →1-month return →
Up and to the right = strong over both horizons. Milbon is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%+80%20×40×605009JYOTHYLAB300740GALAXYSURF2417100013286031933011084928BAJAJCON2657PZC4836502145001206EPC6036300030060012304919.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Milbon is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%605009JYOTHYLAB300740GALAXYSURF0013286031933011084928BAJAJCON2657PZC48365021450030064919.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Milbon is the large dot.

Milbon competitors and peer comparison

How Milbon compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Milbon against its 20 peers (data as of 18 Nov 2026)
Measure4919.TPeer medianRank in peer set
1-month return+10.0%-9.2%2nd highest of 21
6-month return+47.8%-12.0%3rd highest of 21
Distance from 52-week high-2.5%-38.0%highest of 21
Revenue growth (TTM)+7.7%+11.5%9th lowest of 21
Operating margin14.1%8.8%6th highest of 21
Forward P/E25.7×18.5×7th most expensive of 20
Growth the price implies (Req g, 7 yrs)-3.3%4.4%4th least demanding of 16
Growth delivered (Del g)+8.2%+8.9%8th lowest of 16
Hurdle (Req g minus delivered)-11.5 pp-3.3 pp6th least demanding of 16
ROIC minus cost of capital+9.2 pp+5.6 pp8th highest of 21
EV / EBITDA10.4×9.8×6th cheapest of 11
Net debt / EBITDA-1.1×-0.9×6th least indebted of 11

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Milbon 4919.TJapan$743M+48%+8%14%25.7×-3.3%+8.2%
Hangzhou Haoyue Personal Care 605009.SSChina$726M-18%+10%6%17.7×4.4%+7.7%
Jyothy Labs JYOTHYLAB.NSIndia$762M-9%+5%8%40.8×34.5%+8.9%
SYoung 300740.SZChina$816M-48%+14%3%33.4×14.0%+6.1%
Galaxy Surfactants GALAXYSURF.NSIndia$845M+22%+30%9%17.6×18.5%+13.7%
Cosmecca Korea 241710.KSSouth Korea$847M+23%+42%12%16.3×n/an/a
Dencare (Chongqing) Oral Care 001328.SZChina$912M+13%+10%11%27.9×3.7%+10.8%
Runben Biotechnology 603193.SSChina$918M-30%+13%21%18.5×1.5%+28.4%
Tongling Jieya Biologic Technology 301108.SZChina$933M+56%+24%5%52.5×28.5%+0.8%
Noevir 4928.TJapan$978M+7%-3%28%20.4×-12.8%+4.1%
Bajaj Consumer Care BAJAJCON.NSIndia$560M-24%+29%22%19.7×14.8%+5.0%
Shanghai Forest Cabin Cosmetics 2657.HKHong Kong$1.04B+15%+74%18%11.8×11.3%+49.0%
PZ Cussons PZC.LUnited Kingdom$527M+13%+5%11%12.7×-2.3%-2.1%
d'Alba Global 483650.KSSouth Korea$1.13B-55%+49%22%12.0×-6.6%+53.0%
Shanghai Chicmax Cosmetics 2145.HKHong Kong$1.17B-42%+23%8%14.4×-6.1%+21.2%
Qingdao Kingking Applied Chemistry 002094.SZChina$454M-26%+3%4%n/an/an/a
Tianjin Yiyi Hygiene Products 001206.SZChina$429M-15%-8%9%19.9×1.9%+6.3%
Edgewell Personal Care EPCUnited States$1.30B+67%-10%7%14.2×n/an/a
Lafang China 603630.SSChina$414M-19%+5%3%37.6×n/an/a
Chongqing Baiya Sanitary Products 003006.SZChina$1.35B+27%0%3%37.3×28.8%+22.8%
Jinglv Environment Science & Technology 001230.SZChina$392M-25%+28%11%13.9×n/an/a

Questions

Which companies are Milbon's closest peers?
The cockpit's peer set: Hangzhou Haoyue Personal Care (605009.SS), Jyothy Labs (JYOTHYLAB.NS), SYoung (300740.SZ), Galaxy Surfactants (GALAXYSURF.NS), Cosmecca Korea (241710.KS), Dencare (Chongqing) Oral Care (001328.SZ), Runben Biotechnology (603193.SS), Tongling Jieya Biologic Technology (301108.SZ).
Is Milbon expensive compared with its peers?
On forward p/e it trades at 25.7× against a peer median of 18.5×, 7th most expensive of 20 in its peer set. For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -11 pp: the price already allows for a slowdown.
How has Milbon stock performed?
Over six months to 18 Nov 2026 the shares returned +47.8% against -12.0% for the median peer; over one year +58.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.